PrEP can reduce new HIV cases by a third among MSM over next 10 years

A daily pill to prevent HIV infection can reduce new cases among men who have sex with men (MSM) by a third in the US over the next 10 years, according to a new modeling study. The expected significant drop in HIV incidence, however, will depend on clinicians prescribing the medication according to federal guidelines and on patients using it as directed.